Changing infusion lines every 4 days versus every 7 days to prevent catheter infections in the ICU
Official title: Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the Intensive Care Unit ICU
Run by University Hospital, Angers · NCT07183592 · Data updated 2026-11-12
This will test whether changing infusion lines every 7 days instead of every 4 days affects infection risk in adult ICU patients with central venous catheters.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2830 (estimated) |
| Sponsor | University Hospital, Angers Government |
| Locations | 27 sites (Saint-Pierre, La Réunion and 26 other locations) |
| Status | Recruiting |
| Started | May 12, 2026 |
| Main results expected | May 2028 |
| Study ends | December 2028 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT07183592 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult ICU patients with a central venous catheter inserted by venipuncture within 72 hours who are expected to need the catheter for at least 7 days and who can give consent or have proxy/third-party consent.
✕Probably not a fit
Patients with a documented or suspected bloodstream infection at inclusion, catheters in place for more than 72 hours, catheters inserted by guidewire exchange, known allergy to catheter material, confirmed deep vein thrombosis at insertion, or those not expected to require the catheter for ≥7 days are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial enrolls adult ICU patients who have a central venous catheter placed by venipuncture within the past 72 hours and are expected to need it for at least 7 days. Participants are assigned to have infusion sets changed either every 4 days or every 7 days and are followed for catheter-related infections and bloodstream infection rates. The protocol keeps standard insertion and handling precautions the same for both arms and records nursing workload and device-related complications. Safety monitoring will capture any suspected catheter-related infections that require device removal or additional treatment.
Why it matters
Potential benefit: If successful, this could allow safely extending infusion-set replacement intervals, lowering nurse workload and healthcare costs without increasing infections.
How similar studies have gone: Previous evidence is limited and mixed: international guideline recommendations commonly target 4-day changes while the CDC allows up to 7 days, and randomized trials directly comparing 4- versus 7-day replacement are scarce.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria * Adult patient * Any ICU patient with a central venous catheter (inserted by venipuncture) in place for less than 72 hours and with an expected dwell time of at least 7 days * Patient affiliated with or covered by a social security system * Patient who has given verbal consent or written consent from a third party or in the event that the patient is unable to give consent. Exclusion Criteria * Patient with a documented bloodstream infection at the time of inclusion * Patient whose central venous catheter has been in place for more than 72 hours * Patient with suspected catheter-related infection * Patient whose study catheter was inserted using a guidewire exchange * Patient previously enrolled in the study during the same ICU stay * Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as: * Allergy to catheter material * Confirmed deep vein thrombosis at the time of insertion * Inflammatory skin disorder at the insertion site * Patient admitted for extensive burns * Inadequate understanding of the French language * Pregnant, breastfeeding, or postpartum woman * Person deprived of liberty by judicial or administrative decision * Person receiving involuntary psychiatric care * Person under legal guardianship or other legal protection measure
Where it's running
-
Angers University Hospital
Angers, France Recruiting -
La Réunion University Hospital
Saint-Pierre, La Réunion, France Not yet recruiting -
Albi Hospital
Albi, France Not yet recruiting -
Belfort Hospital
Belfort, France Not yet recruiting -
Bourges Hospital
Bourges, France Not yet recruiting -
Caen University Hospital
Caen, France Not yet recruiting
Show 21 more locations
-
CH Carcassonne
Carcassonne, France Not yet recruiting -
Chartres Hospital
Chartres, France Not yet recruiting -
Cholet Hospital
Cholet, France Not yet recruiting -
Colombes Hospital
Colombes, France Not yet recruiting -
Corbeil-Essonnes Hospital
Corbeil-Essonnes, France Not yet recruiting -
AP-HP - Henri Mondor Hospital
Créteil, France Not yet recruiting -
Dijon University Hospital
Dijon, France Not yet recruiting -
Garches Hospital
Garches, France Not yet recruiting -
CH Le Mans
Le Mans, France Not yet recruiting -
Le Puy en Velay Hospital
Le Puy-en-Velay, France Not yet recruiting -
Macon Hospital
Mâcon, France Not yet recruiting -
Nantes University Hospital
Nantes, France Not yet recruiting -
Orleans University Hospital
Orléans, France Not yet recruiting -
AP-HP - Tenon Hospital
Paris, France Not yet recruiting -
AP-HP - Saint Louis
Paris, France Not yet recruiting -
Pontoise Hospital
Pontoise, France Not yet recruiting -
CHU Rennes - service MIR
Rennes, France Not yet recruiting -
CHU Rennes - service Réa chir
Rennes, France Not yet recruiting -
CH Saint-Nazaire
Saint-Nazaire, France Not yet recruiting -
Strasbourg University Hospital
Strasbourg, France Not yet recruiting -
CHU Tours
Tours, France Not yet recruiting
Study contacts
- Principal investigator: Carole Haubertin — University Hospital, Angers
- Study coordinator: Carole Haubertin
- Email: Carole.Haubertin@chu-angers.fr
- Phone: +332 41 35 40 82
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Muscle Mass and Blood Gases in ICU Patients
This study tests whether muscle mass in adults in the ICU is related to oxygen levels and other blood gas and vital signs.
-
Permissive lung-protective ventilation in invasively ventilated adults
This study tests whether lowering the breathing rate during mechanical ventilation is better than standard lung-protective ventilation for adults in the ICU who need invasive ventilation.
-
Heart rate variability feedback to help practitioners make better patient decisions
This study tests whether giving healthcare workers HRV feedback during care improves how quickly and safely they respond to ventilator events and bedside needs.
-
Does a CDT level at ICU admission predict short-term outcomes in critically ill adults?
This study tests whether high carbohydrate-deficient transferrin levels at ICU admission can predict worse short-term outcomes for adults with critical illness from emergency department admissions.
-
Dexcom G7 CGM in critically ill adults after major abdominal surgery or solid organ transplant
This study tests how accurately the Dexcom G7 continuous glucose monitor tracks glucose in ICU patients after major abdominal surgery or solid organ transplantation who need tight insulin control.
-
What predicts death in the ICU? Analyzing APACHE II in Colombian patients
This study tests how well the APACHE II score predicts ICU mortality in adults treated at a Colombian hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.